RecallRadar

FDA Device recall Z-1967-2023

bellavista 1000e Ventilator, Catalogue Number 301.100.130

On 2023-06-21 the FDA classified a Class II recall of bellavista 1000e Ventilator, Catalogue Number 301.100.130 by Vyaire Medical, citing vyaire Medical identified two patient safety risks during the use of the bellavista 1000 and bellavista 1000e: 1. Under certain conditions of use, the touchscreen may become unres….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1967-2023
ClassificationClass II
Statuscompleted
Initiated2023-05-05
Published2023-06-21
Last updated2026-09-13 11:56 UTC
CompanyVyaire Medical
DistributionUS

Product

bellavista 1000e Ventilator, Catalogue Number 301.100.130; Continuous Use Ventilator

Reason

Vyaire Medical identified two patient safety risks during the use of the bellavista 1000 and bellavista 1000e: 1. Under certain conditions of use, the touchscreen may become unresponsive and the device application stops responding (APP Hang). When this occurs, if the user continues to interact with the touchscreen, a message will appear that states DeviceSoftware.Application is not responding or a decommission screen will appear on the user interface. The ventilator will issue both an audible and visual alarm. Ventilation continues without interruption with the settings applied prior to the APP Hang error. 2. The potential for a use error has been identified if the operator applies the proposed settings without confirming the settings are suitable for the patient.

Identifiers

code_infoUDI/DI 07640149381115 and 07640149388879, ALL serial numbers with Software Version 6.1.0.2 and 6.1.1

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: completed.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1967-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.